To view this email as a web page, click here

Subscribe

Advertise

 

 

 

 

 

 

October 12, 2018

Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications.

Featured Story

Novartis cozies up to Silicon Valley with new lab

Novartis is set to open innovation labs around the world to connect with tech companies. The labs, the first of which has opened in San Francisco, will serve as a bridge between companies developing R&D-enhancing technologies and the broader Novartis business.

Top Stories Of The Week

GlaxoSmithKline to hold on to its antibiotics business, but nearly 200 workers will go

GlaxoSmithKline has decided to keep its cephalosporin antibiotics business but reorganize it to be more efficient, cutting nearly 200 jobs at its Ulverston site in the U.K.

Bose wins FDA green light for direct-to-consumer hearing aid

The FDA has cleared a direct-to-consumer hearing aid, developed by speaker manufacturer Bose, potentially opening the door for other consumer-focused electronics companies.

Pfizer poaches Quest executive to spearhead digital, but the rest of Bourla's supporting cast looks familiar

Some new CEOs fill out their executive team roster over time as leaders from the previous regime make their exits. Not Pfizer’s. On Tuesday, the New York company unveiled the list of executives that will support incoming chief Albert Bourla when he takes the baton from retiring Ian Read on Jan. 1.

Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts

Last week, Eli Lilly unveiled positive data for a new diabetes drug with serious potential to disrupt the GLP-1 market. But its rivals don't need to hunker down, analysts said.

Affimed tumbles as it puts brakes on T cell engager

Affimed has halted work on two phase 1 trials of its lead T cell engager AFM11 for blood cancers after a death and two life-threatening events.

Merck snags national VA contract for its Remicade biosimilar thanks to discount pricing offer

Merck's Remicade biosimilar hasn't made much of a splash on the market, but the company won a national contract with the Department of Veterans Affairs due to a pricing offer that beat out rivals.

Spark plans 2019 clinical trial of gene therapy for Pompe disease after positive mouse study

Spark Therapeutics announced encouraging preclinical data on SPK-3006, its investigational gene therapy to treat Pompe disease. The inherited lysosomal storage disease causes the sugar glycogen to build up in muscles and organs such as the heart, impairing their function.

With nod in older adults, Merck drives HPV shot Gardasil 9 into big new market

With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients. But now, Merck has another chance—and so do the men and women who didn't get their shots the first time around.

Takeda spinoff GenAhead Bio inks partnership with ERS Genomics on CRISPR/Cas9 patents

Takeda biotech spinoff GenAhead Bio has inked a nonexclusive license deal to access ERS Genomics’ CRISPR/Cas9 patents for genome editing technology.

Enrollment Showcase

Online Graduate Programs Designed for Your Career

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.

Resources

[Whitepaper] Unlocking New Business Value in Life Sciences with Digital Technology

Collaborate in a digital world to improve patient outcomes.

[Industry Research] Unifying Clinical Applications is an Industry-wide Priority

Industry Research: Read the 2018 Unified Clinical Operations Report to find out how pharmas and CROs are evolving clinical trial processes.

[Whitepaper] Is Your In-House Strategy Ready For The Uncertainties Of Biologic Drug Development?

Read this whitepaper to learn more about two main areas where a drug developer can face significant obstacles during biologics development.

[Research] Linguistic and Cultural Considerations When Implementing a Global BYOD Study

Examine the linguistic and cultural considerations of global eCOA and BYOD.

[eBook] Healthcare and Life Sciences - Data Value Chain

Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data.

[Infographic] Flexible. Scalable. Proactive.

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[Case Study] FSP Insourcing – Relationship Growth Built on Results, Trust

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[POCKET GUIDE] 3 Steps To Supercharge Your Literature Search

Go from Search to Full-Text Scientific Papers in a Single Click!

[Whitepaper] How to Re-Design your Regulatory Capabilities

A top 20 pharma and growing biotech re-engineer regulatory processes.

[Whitepaper] The Future of Pharmacovigilance: Leveraging Technology and Automation

Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be!

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

[eLearning] BIOAVAILABILITY 101

Develop a basic understanding of principles and concepts of bioavailability of oral drugs.

.